NL-OMON36743
Completed
Not Applicable
Optimized heart failure therapy through continuous monitoring. The PHARAO multi-centre study - PHARAO study
Kennemer Gasthuis0 sites30 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- heart failure
- Sponsor
- Kennemer Gasthuis
- Enrollment
- 30
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •heart failure
- •objective systolic or diastolic heart failure
- •CHADS score 2 or more
- •No indication ICD/PM or OAC
- •No atrial fibrillation
- •No planned or expected revascularisation or valveoperation \< 3 months
Exclusion Criteria
- •life expectancy \< 1 year
- •No informed concent
- •Participation in other study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Therapy optimalisation of heart failure in primairy care Utrecht (TOPHU)heart failure10019280NL-OMON35310niversitair Medisch Centrum Utrecht700
Not yet recruiting
Phase 4
ovel Interventions in Heart Failure with Preserved Ejection Fraction using TadalafilHeart Failure with Preserved Ejection FractionCardiovascular - Other cardiovascular diseasesACTRN12612000684820South Australian Health and Medical Reseasrch Institute20
Not yet recruiting
Phase 4
ovel Interventions in Heart Failure with Preserved Ejection Fraction using ivabradineHeart Failure with Preserved Ejection FractionCardiovascular - Other cardiovascular diseasesACTRN12612000710820South Australian Health and Medical Research Institute20
Completed
Not Applicable
Pilot study for the treatment of heart failure with PycnogenolHeart failureCirculatory SystemISRCTN22412590Kyoto University (Japan)30
Completed
Not Applicable
eural Cardiac Therapy for Heart Failure Studycardiac remodelingHeart failure10019280NL-OMON46859Boston Scientific20